Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

被引：0

作者：

Rik Vandenberghe

Juha O. Rinne

Mercè Boada

Sadao Katayama

Philip Scheltens

Bruno Vellas

Michael Tuchman

Achim Gass

Jochen B. Fiebach

Derek Hill

Kasia Lobello

David Li

Tom McRae

Prisca Lucas

Iona Evans

Kevin Booth

Gerald Luscan

Bradley T. Wyman

Lisa Hua

Lingfeng Yang

H. Robert Brashear

Ronald S. Black

机构：

[1] Alzheimer Research Centre KU Leuven,University Hospitals Leuven, Department of Neurosciences

[2] University of Turku and Turku University Hospital,Turku PET Centre and Division of Clinical Neurosciences

[3] Fundació ACE,Graduate School of Biomedical Sciences

[4] Barcelona Alzheimer Treatment and Research Center,Alzheimercentrum VUmc, Neurology

[5] Hiroshima University,Department of Neurology, University Hospital Mannheim

[6] VU University Medical Center,undefined

[7] CHU Toulouse,undefined

[8] Gérontopôle,undefined

[9] Palm Beach Neurological Center,undefined

[10] University Medical Centre Mannheim,undefined

[11] Center for Stroke Research Berlin (CSB),undefined

[12] Charité Universitätsmedizin Berlin,undefined

[13] IXICO Ltd.,undefined

[14] The London Bioscience Innovation Centre,undefined

[15] Pfizer Inc.,undefined

[16] Pfizer Inc.,undefined

[17] Pfizer Global Research and Development (PGRD),undefined

[18] Pfizer Ltd.,undefined

[19] Pfizer Inc.,undefined

[20] Janssen Alzheimer Immunotherapy Research & Development,undefined

[21] LLC,undefined

来源：

Alzheimer's Research & Therapy | / 8卷

关键词：

Alzheimer’s disease; Bapineuzumab; Immunotherapy; Amyloid β; Clinical trial; ARIA-E; Vasogenic edema;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimer's Disease: Two Phase 3 Studies [J].

Harrington, C. ;

Sawchak, S. ;

Chiang, C. ;

Davies, J. ;

Donovan, C. ;

Saunders, A. M. ;

Irizarry, M. ;

Jeter, B. ;

Zvartau-Hind, M. ;

van Dyck, C. H. ;

Gold, M. .

CURRENT ALZHEIMER RESEARCH, 2011, 8 (05) :592-606

[42] Phase II Crossover Trial of Varenicline in Mild-to-Moderate Alzheimer's Disease [J].

Kim, Seong Yoon ;

Choi, Seong Hye ;

Rollema, Hans ;

Schwam, Elias M. ;

McRae, Tom ;

Dubrava, Sarah ;

Jacobsen, Janice .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2014, 37 (3-4) :232-245

[43] Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Bapineuzumab: A Single-Ascending-Dose Study in Patients With Mild to Moderate Alzheimer Disease [J].

Lu, Ming ;

Brashear, H. Robert .

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (03) :326-335

[44] Anti-β-Amyloid Immunotherapy for Alzheimer's Disease: Focus on Bapineuzumab [J].

Panza, Francesco ;

Frisardi, Vincenza ;

Imbimbo, Bruno P. ;

Seripa, Davide ;

Paris, Francesco ;

Santamato, Andrea ;

D'Onofrio, Grazia ;

Logroscino, Giancarlo ;

Pilotto, Alberto ;

Solfrizzi, Vincenzo .

CURRENT ALZHEIMER RESEARCH, 2011, 8 (08) :808-817

[45] Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease [J].

Mecocci, Patrizia ;

Polidori, Maria Cristina .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (05) :631-638

[46] Neuropsychological rehabilitation in mild and moderate Alzheimer's disease patients [J].

Avila, Renata ;

Carvalho, Isabel A. M. ;

Bottino, Cassio M. C. ;

Miotto, Eliane C. .

BEHAVIOURAL NEUROLOGY, 2007, 18 (04) :225-233

[47] Autonomic Dysfunction in Patients with Mild to Moderate Alzheimer's Disease [J].

Jensen-Dahm, Christina ;

Waldemar, Gunhild ;

Jensen, Troels Staehelin ;

Malmqvist, Lasse ;

Moeller, Michelle Mai ;

Andersen, Birgitte Bo ;

Hogh, Peter ;

Ballegaard, Martin .

JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (03) :681-689

[48] Monotherapy Is Good Enough for Patients with Mild-to-Moderate Alzheimer's Disease: A Network Meta-analysis of 76 Randomized Controlled Trials [J].

Tsoi, Kelvin K. F. ;

Chan, Joyce Y. C. ;

Chan, Felix C. H. ;

Hirai, Hoyee W. ;

Kwok, Timothy C. Y. ;

Wong, Samuel Y. S. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (01) :121-130

[49] Memantine in the treatment of mild-to-moderate Alzheimer's disease [J].

Cosman, Kelly M. ;

Boyle, Llsa L. ;

Porsteinsson, Anton P. .

EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) :203-214

[50] Apraxic disturbances in patients with mild to moderate Alzheimer's disease [J].

Derouesné, C ;

Lagha-Pierucci, S ;

Thibault, S ;

Baudouin-Madec, V ;

Lacomblez, L .

NEUROPSYCHOLOGIA, 2000, 38 (13) :1760-1769

← 1 2 3 4 5 →